Incyte Genomics Inc. (INCY)

NASDAQ

$115.97

$+2.86

(+2.53%)

Regular Market

Incyte Genomics Inc. (INCY) Live Price Chart

Last updated: ⁦2026-10-20 16:46:40⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Incyte Genomics Inc. (INCY) operates in the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH sector and is listed on NASDAQ. The stock is currently priced at $115.97, with a market capitalization of $22.92B and a P/E ratio of 14.24. Over the past 52 weeks, its price has ranged from $84.02 to $132.60. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$22.92B
Open	$113.78
Day's High	$153.15
Day's Low	$1.85
Previous Close	$113.25
Volume	337.33K
Average Volume	1.64M
P/E Ratio	14.24
52-Week High	$132.60
52-Week Low	$84.02
Dividend Yield	--
Earnings Date	--

Incyte Genomics Inc. (INCY) Stock Price Today

Incyte Genomics Inc. (INCY) is currently trading at $115.97 as of 2026-10-20 16:45:00, up 2.40% ($2.72) from the previous close of $113.25

During today's regular trading session, INCY has traded between $1.85 and $153.15, with a trading volume of 337.33K shares. The current price is near the upper end of today's range.

Incyte Genomics Inc. (INCY) 7-Day Stock Price Change

Over the past seven days, Incyte Genomics Inc. (INCY) moved from $112.79 to $115.97, representing a gain of 2.82% ($3.18).

The stock traded between $107.78 and $116.99 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.

The average daily volume was 1.68 million shares, down versus the previous seven-day period, indicating lower trading activity.

INCY 52-Week Price Position

Position in Range: 65.8%

52W Low$84.02

52W High$132.60

INCY is currently trading at $115.97, placing it 65.8% of the way from its 52-week low of $84.02 to its 52-week high of $132.60. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Incyte Genomics Inc. (INCY)?

Incyte focuses on the discovery and development of small-molecule drugs. The firm's leading drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis and 2022 for vitiligo. Incyte's pipeline includes an array of oncology and dermatology programs.

Incyte Genomics Inc. Information

Industry	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Employees	2844
Exchange	NASDAQ
Company Website	https://www.incyte.com

How to Buy Incyte Genomics Inc. (INCY) Stock on MEXC

Eligible investors can buy real shares of Incyte Genomics Inc. (INCY) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for INCY and Place Your Order

Open the RealStocks trading page and search for INCY. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Incyte Genomics Inc. (INCY) stock price today?

Incyte Genomics Inc. (INCY) is currently trading at $ 115.97, up 2.40% ($2.72) from the previous close of $ 113.25. Intraday prices update in real time during regular trading hours.

2.Is INCY stock going up or down today?

As of 2026-10-20 16:45:00, INCY is trading at $ 115.97, up 2.40% ($2.72) from its previous close of $ 113.25. The stock has traded between $ 1.85 and $ 153.15 during today’s regular session. Past price movements do not guarantee future results.

3.What is INCY pre-market price?

As of 2026-10-20 16:45:00, INCY is trading at $ 113.56 in pre-market trading, up 0.27% ($0.31) from the previous close of $ 113.25. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is INCY after-hours price?

As of 2026-10-20 16:45:00, INCY is trading at $ 113.26 in after-hours trading, up 0.00% ($0.00) from the regular-session close of $ 113.25. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is INCY stock trading now?

INCY trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does INCY sit relative to its 52-week high and low?

Over the past 52 weeks, INCY has traded between a low of $ 84.02 and a high of $ 132.60. At $ 115.97, the stock is positioned 65.8% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Incyte Genomics Inc. in?

Incyte Genomics Inc. (INCY) operates in the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Incyte Genomics Inc.'s market capitalization and where is it listed?

Incyte Genomics Inc. is listed on the NASDAQ exchange with a market capitalization of $ 22.92B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is INCY valued in terms of P/E ratio and EPS?

INCY trades at a P/E ratio of 14.24, based on trailing-twelve-month EPS of $ 7.95. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Incyte Genomics Inc. pay a dividend?

Incyte Genomics Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.